Related Experiment Video
Updated: Mar 9, 2026

Exploring Arterial Smooth Muscle Kv7 Potassium Channel Function using Patch Clamp Electrophysiology and Pressure Myography
Published on: September 14, 2012
Overexcited MaxiK and KATP channels underlie obstructive jaundice-induced vasoconstrictor hyporeactivity of arterial
Ya-Wei Yuan1, Long Wang2, Zhan-Ying Lu3
1Department of Anesthesiology, Renji Hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai, China.
Abstract:
Substantial evidence has shown that obstructive jaundice can induce vascular hyporesponsiveness. The present study was designed to investigate mechanisms of MaxiK channel and KATP underlying cholestasis-induced vascular dysfunction. The isolated thoracic aorta was used to explore norepinephrine (NE)-induced contraction. The function of MaxiK and KATP channels were investigated using whole-cell patch clamp recording. Compared with Sham group, NE-induced vascular contraction was blunted after bile duct ligation (BDL), which could not be ameliorated significantly after endothelial denudation. Charybdotoxin and glibenclamide induced a more pronounced recovery from vascular hyporesponsiveness to NE in BDL group compared with Sham group. BDL significantly promoted the charybdotoxin sensitive MaxiK current and KATP current in isolated aortic smooth muscle cells. In addition, the expression of auxiliary subunits (MaxiK-β1 and SUR2B) rather pore-forming subunits (MaxiK-α and Kir6.1) was significantly up-regulated after BDL. These findings suggest that MaxiK and KATP channels play an important role in regulating vascular hyporesponsiveness in BDL rats.
Insights
Obstructive jaundice causes vascular hyporesponsiveness by altering MaxiK and KATP channels. Bile duct ligation in rats promoted these channel currents, contributing to vascular dysfunction.
Area of Science:
- Physiology
- Vascular Biology
- Channelopathies
Background:
- Obstructive jaundice is known to induce vascular hyporesponsiveness.
- The underlying molecular mechanisms, particularly ion channel involvement, remain incompletely understood.
Purpose of the Study:
- To investigate the roles of MaxiK (BK) channels and ATP-sensitive potassium (KATP) channels in cholestasis-induced vascular dysfunction.
- To explore the impact of bile duct ligation (BDL) on vascular reactivity and ion channel function in rat thoracic aorta.
Main Methods:
- Isolated thoracic aorta from sham-operated and BDL rats were used to assess norepinephrine (NE)-induced contraction.
- Whole-cell patch clamp recordings were performed on isolated aortic smooth muscle cells to investigate MaxiK and KATP channel function.
- The expression levels of MaxiK and KATP channel subunits were analyzed.
Main Results:
- NE-induced vascular contraction was significantly blunted in BDL rats compared to sham controls.
- Administration of charybdotoxin (MaxiK channel blocker) and glibenclamide (KATP channel blocker) partially restored vascular responsiveness in BDL rats.
- BDL significantly increased MaxiK and KATP channel currents in aortic smooth muscle cells, with a notable upregulation of auxiliary subunits (MaxiK-β1, SUR2B).
Conclusions:
- MaxiK and KATP channels are critically involved in the vascular hyporesponsiveness observed in rats with obstructive jaundice.
- The functional upregulation of these channels, particularly their auxiliary subunits, contributes to cholestasis-induced vascular dysfunction.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Autoregulation of Blood Flow
Chemical Signaling in Autoregulation
Chemical signaling operates at the precapillary sphincter level, inciting either contraction or relaxation....
Antihypertensive Drugs: Vasodilators
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Direct-Acting Cholinergic Agonists: Pharmacological Actions

